ABOUT

Eskayef Pharmaceuticals Ltd. is one of the leaders in Bangladesh’s pharmaceutical industry. With its presence across the world, it has earned coveted accreditations from the US FDA, UK MHRA, EU EMA, TGA Australia, and more. Eskayef spread its wings in 1990 when the Bangladeshi operations of SmithKline & French were acquired by Transcom Group.

Eskayef prides itself on being a trusted manufacturer of top-quality medicine for Bangladesh and the world.

Milestones

1979

Multinational SmithKline & French (SK&F) enters Bangladesh


1990

Transcom acquires SmithKline & French (SK&F) and becomes Eskayef Bangladesh Ltd


2017

Eskayef Bangladesh Ltd. emerges as Eskayef Pharmaceuticals Ltd. to go more global

HISTORY

1999

Pioneering of Pellet Technology in Bangladesh

2001

  • Acquisition of Squibb Plant at Tongi
  • Beginning of Animal Health Business
  • 2003-2004

    Beginning of International Business

    2008

  • Accreditation by UK MHRA & EU GMP
  • Commissioning of Dedicated Cephalosporin Plant
  • 2009-2010

    Accreditation by TGA Australia

    2011-2012

  • Accreditation by VMD UK
  • Starts manufacturing Insulin for Novo Nordisk
  • 2013

  • Commissioning of Sterile Unit at Tongi
  • Eskayef ventures into Eyecare segments by launching Ophthalmic Drops
  • 2014-2015

  • Approval by UNICEF
  • Acquisition of Salna Plant
  • 2016

    Commissioning of Rupgonj Plant

    2017

  • Commissioning of future-ready and state-of the art manufacturing plant, Faraaz Ayaaz Hossain Building and its accreditation by UK MHRA.
  • Launching of Carbapenem products from dedicated state-of-the-art facility
  • 2018

  • With the mission of fighting together and winning the battle against Cancer, Eskayef launches oncology products from its dedicated Oncology plant with 1st time in Bangladesh ISOLATOR technology
  • Eskayef establishes its state-of the art dedicated R&D Centre at Salna
  • 2020

  • Eskayef redefines its capability by introducing Remivir injection, the 1st generic Remdesivir brand in the world for treating hospitalized Covid-19 patients
  • Eskayef Oncology manufacturing plant receives EU GMP Approval, which is the 1st and only EU GMP certified Oncology Facility in Bangladesh
  • 2021

  • Eskayef introduces Monuvir brand, the 1st Generic Molnupiravir brand in the world for the treatment of COVID-19 patients
  • Eskayef introduces Paxovir brand, the 1st Generic Nirmatrelvir + Ritonavir brand in the world for the treatment of COVID-19 patients
  • Eskayef Oncology manufacturing plant receives ANVISA Brazil Approval, which is the 1st and only ANVISA certified Oncology Facility in Bangladesh
  • 2022

    The Faraaz Ayaaz Hossain Building manufacturing facility receives the prestigious US FDA approval.

    Global Quality Standards

    International Accreditations

    YEAR: 2022

    YEAR: 2008, 2011, 2014, 2017

    YEAR: 2011, 2014, 2017

    Faraaz Ayaaz Hossain Building Tablet, Capsule & Pellets (2017) & Eskayef Oncology Sterile injection & Oral Solid (2020)

    YEAR: 2010, 2012, 2015

    Eskayef Oncology Sterile injection (2021)

    Multinational Partners

    Eskayef Pharmaceuticals Limited is recognized as a model of trust and efficiency by blue chip multinationals.


    Novo Nordisk

    Eskayef has been manufacturing insulin for Novo Nordisk, from its state-of-the-art & dedicated insulin manufacturing facility since 2012.In January 2018, Eskayef signed a historic agreement with Novo Nordisk to become its first-ever partner to contract manufacture its cutting-edge modern penfill insulin.In 2022, Eskayef inaugurated its state-of-the-art facility to manufacture modern penfill insulin for Novo Nordisk.


    Servier

    Eskayef is manufacturing products for Servier, France since 2009.

    Fight Against COVID-19

    Eskayef exports to 67 countries
    across 6 continents in the world.

    Leadership Team

    Simeen Rahman

    Managing Director & CEO

    Dr. Mohammad Mujahidul Islam

    Executive Director - Marketing and Sales

    Mohammed Ikhtiar Hossain

    Executive Director - Technical Services

    Md. Motiar Rahman

    Executive Director - Quality Assurance

    Mohammad Mostafa Hassan

    Executive Director - Commercial & HR

    Kazi Mahbub Masud

    Executive Director - Finance

    K.M. Ariful Islam

    Executive Director - Plant

    Abdullah Al Wahid

    Executive Director - Plant

    Know More